|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Deferred income taxes | |||||
| Provision for credit losses | |||||
| Depreciation and amortization | |||||
| Amortization and accretion of premiums/discounts on investment securities | |||||
| Amortization of operating lease right-of-use assets | |||||
| Stock-based compensation cost | |||||
| Increase in value of bank-owned life insurance | |||||
| Purchase accounting accretion, net | |||||
| Originations of loans held for sale | |||||
| Proceeds on loans held for sale | |||||
| Realized loss (gain) on mortgage loans sold | |||||
| Realized loss (gain) on non-mortgage loans sold | |||||
| Servicing rights capitalized upon sale of mortgage loans | |||||
| (Increase) in value of bank-owned life insurance | |||||
| Realized loss (gain) on sale of premises and equipment | |||||
| Realized loss (gain) on derivative instruments | |||||
| Realized loss (gain) on sale of foreclosed assets | |||||
| Realized loss (gain) on sale of investment securities | |||||
| Realized loss (gain) on BOLI mortality | |||||
| Change in fair value of mortgage servicing rights | |||||
| Realized loss (gain) on servicing rights | |||||
| Realized loss (gain) on sale of ESOP trustee line of business | |||||
| Net change in: | |||||
| Accrued interest receivable | |||||
| Other assets | |||||
| Accrued expenses and other liabilities | |||||
| Net cash provided (used) by operating activities | |||||
| Investing activities | |||||
| Proceeds from sales of trading investment securities | |||||
| Purchases of trading investment securities | |||||
| Proceeds from sales or calls of investment securities available-for-sale | |||||
| Proceeds from maturities of investment securities available-for-sale | |||||
| Purchases of investment securities available-for-sale | |||||
| Proceeds from sales or calls of investment securities held-to-maturity | |||||
| Proceeds from calls of investment securities held-to-maturity | |||||
| Proceeds from maturities and paydowns of investment securities held-to-maturity | |||||
| Proceeds from sale of non-mortgage loans held for sale | |||||
| Net (increase) decrease in loans | |||||
| Net (increase) decrease in FHLB stock | |||||
| Purchases of FHLB stock | |||||
| Sales of FHLB stock | |||||
| Total net (increase) decrease in FHLB stock | |||||
| Net cash received (paid) for business combinations | |||||
| Purchases of BOLI | |||||
| Proceeds from BOLI mortality claim | |||||
| Proceeds from sale of premises and equipment | |||||
| Purchases of premises and equipment | |||||
| Proceeds from sales of foreclosed assets | |||||
| Net cash provided (used) by investing activities | |||||
| Financing activities | |||||
| Net increase (decrease) in deposits | |||||
| Net increase (decrease) in short-term borrowings with maturities of three months or less | |||||
| Repayments of long-term debt | |||||
| Cash dividends paid on common stock | |||||
| Repurchase of common stock | |||||
| Net cash provided (used) by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental Cash Flow Disclosures | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Loan collateral transferred to foreclosed assets | |||||
| Cash dividends declared, not paid | |||||
| Cash and cash equivalents acquired | |||||
| Supplemental Disclosures of Noncash Investing and Financing Activities | |||||
| Loan collateral transferred to foreclosed assets | |||||
| Premises and equipment transferred to other assets | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities, net | |||||
| Change in fair value hedges presented within residential real estate loans and other assets | |||||
| Loans transferred to non-mortgage loans held for sale | |||||
| Noncash assets acquired | |||||
| Liabilities assumed | |||||
| Issuance of common stock for the acquisition | |||||
| Net noncash acquired | |||||
Loading...
